Logo Lanfrica

P05-06: Pharmacokinetics of Amitriptyline in Algerian Patients with Depressive Disorders: Low Cyp2D6 activity?

Créateur:
K. M.
Éditeur:
Elsevier BV
Hôte:

Languages

Arabic, Algerian Spoken

Licenses

https://www.elsevier.com/tdm/userlicense/1.0/https://www.elsevier.com/legal/tdmrep-license

Similaires

Depressive disorders in Ethiopia

ABSTRACT: Fifty‐two depressed patients were selected from out‐patients at the psychiatric departme

Prevalence and correlates of major depressive disorders among patients with cancer at Kamuzu Central Hospital in Malawi

Abstract Background Depressive disorders, with prevalence varying widely by setting, are

Assessment of Thyroid Disorders among Patients Diagnosed with Major Depressive Disorder and Generalized Anxiety Disorder in a Tertiary Hospital in Maiduguri, Nigeria

Background: Thyroid dysfunction is closely associated with psychiatric disorders, particularly Major

Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With Tuberculosis

Abstract Background Further work is require

CYP2D6 Genotype Predicts Plasma Concentrations of Tamoxifen Metabolites in Ethiopian Breast Cancer Patients

Tamoxifen displays wide inter-individual variability (IIV) in its pharmacokinetics and treatment out

Population pharmacokinetics of artemether–lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria

Aims: Resistance to the artemisinins and the artemisinin‐based combination therapy (ACT) partner dru